Audit a URL →

Sign in Sign up free

Loading…

Weekly · Sunday Morning

Five longevity claims.
Worth your time.
Every Sunday.

Last Sunday

Rapamycin extends mouse lifespan 9–14%
NAD+ precursors reverse aging in humans
Blue-light glasses improve sleep quality
Walking 10 min after meals blunts glucose
Verdict change — caffeine half-life downgraded

5 audits·1 verdict change·0 affiliate links·Every Sunday

Joining 1,247 readers — founders, MDs, and longevity-obsessed people who fact-check their own health decisions.

Browse

Decisions Claims Content Creators

Product

Audit a URL Sunday roundup API (soon)Pricing

About

FAQ Methodology Editorial Standards Corrections Press & brand RSS feed

Legal

Terms of Service Privacy Policy DMCA

Finally, something serious in this space.
Because we actually read the papers.

© 2026 Whalespan. Independent, evidence-graded longevity.

#99 – Peter Hotez, M.D., Ph.D.: Continuing the conversation on COVID-19 — Whalespan

Content›Video›#99 – Peter Hotez, M.D., Ph.…

#99 – Peter Hotez, M.D., Ph.D.: Continuing the conversation on COVID-19

Peter Attia1h 6m · 2020-03-21

Claims Made

81

Claims Supported

47

Support Rate

58%

Support rate

47 of 81 claims supported

47 supported34 partial / not

Claims from this content

30

◐Partially SupportedDroplet and contact transmission (via contaminated surfaces) are important modes of transmission.◐Partially SupportedConvalescent serum can be used as a prophylaxis to prevent healthcare workers and first responders from getting sick.◐Partially SupportedThere is likely durable short-term immunity to SARS-CoV-2, as demonstrated in a macaque monkey study.◐Partially SupportedSurvivors of SARS-CoV-1 experienced significant cardiac and pulmonary disease 10 years after infection.Partially Supported

More from Peter Attia

Peter Attia on Zone 2 Cardio

Peter Attia on Rapamycin (with Matt Kaeberlein)

Attia walks back the clinic protocol: too aggressive for healthy adults

Discussion

Native comments, Twitter mentions, and Reddit threads about this content — surfaced together so the conversation isn't fragmented across platforms.

M

Share your read of this content…

Posting publicly as you · linked to your social profiles

Sort by:

AV

A. Volkovreader

4h

Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.

NP

N. Park

2d

Would love a "what would change this verdict" RSS feed. Sign me up if it exists.

◐

The homology between SARS-CoV-1 and SARS-CoV-2 spike proteins suggests cross-effectiveness of targets.

◐Partially SupportedThe actual to confirmed COVID-19 case multiplier is estimated to be around 25, with some models suggesting it could be as high as 45-50.

◐Partially SupportedColchicine was not helpful when given to patients with severe COVID-19.

◐Partially SupportedThere was at least a month to prepare for COVID-19 in the United States after initial awareness.

◐Partially SupportedSmoking may upregulate the ACE2 receptor, potentially increasing susceptibility to the virus that causes COVID-19.

◐Partially SupportedPeople with blood type O may have a reduced risk of COVID-19 infection.

◐Partially SupportedWiping down Amazon packages with Clorox or approved alcohol wipes is a potential measure to reduce fomite transmission risk of SARS-CoV-2, though the overall risk from mail is considered low.

◐Partially SupportedA significant amount of acute heart injury is observed in COVID-19 patients.

◐Partially SupportedA lack of control during a pandemic can manifest as significant irritability, potentially posing a long-term health risk.

◐Partially SupportedTherapeutic targets for SARS-CoV-1 might be applicable to SARS-CoV-2 due to commonalities in their spike proteins.

◐Partially SupportedSome ARBs may work against COVID-19 through anti-inflammatory effects in the angiotensin pathway, not by interfering with ACE2 binding.

◐Partially SupportedHydroxychloroquine is proposed as an ideal COVID-19 treatment due to its low cost, oral bioavailability, and ease of use.

◐Partially SupportedConvalescent antibodies and repurposed drugs are promising new technologies for treating COVID-19.

◐Partially SupportedACE2 inhibitors and ARBs are being evaluated for COVID-19 treatment.

◐Partially SupportedBeta coronaviruses, including SARS, MERS, and SARS-CoV-2, have emerged on a regular basis in the 21st century, suggesting they will continue to emerge.

◐Partially SupportedExposure to cable news can negatively impact mental well-being.

◐Partially SupportedHeating takeout food to north of 140-150 degrees Fahrenheit is likely sufficient to kill SARS-CoV-2.

◐Partially SupportedHealthcare providers are a highest priority target for vaccine development against coronaviruses.

◐Partially SupportedSharing data on preprint servers like bioRxiv and medRxiv has become a routine and important form of scientific communication.

◐Partially SupportedThe furin protease in SARS-CoV-2 is a potential drug target.

◐Partially SupportedIn the US, approximately one-third of hospitalized COVID-19 patients are between the ages of 20 and 40.

◐Partially SupportedReceiving three to four hours of sleep for several consecutive days can lead to significant stress and emotional reactions.

?Limited ResearchACE2 inhibitors and ARBs have mixed results regarding their effect on COVID-19.

◐Partially SupportedThe probability of virus transmission from Amazon packages is low, despite the virus's ability to survive for hours on cardboard.

◐Partially SupportedAnxiety and lack of sleep can cause uncharacteristic emotional outbursts.

◐Partially SupportedCamostat mesylate, a serine protease inhibitor, shows preliminary results in interfering with viral entry by inhibiting the furin protease.